Colonizing germ-free mice with fecal microbiota from a preterm infant with normal weight gain, but not from one with poor weight gain, drives a coordinated ileal maturation program (villus and crypt growth, crypt cell proliferation, goblet- and Paneth-cell differentiation, tight-junction assembly). Which specific bacterial taxa or combinations of taxa — the 'pioneer settlers' — are necessary to induce this maturation, and which microbial molecular mediators (short-chain fatty acids such as butyrate, folate, bile acids, vitamins, or other metabolites) deliver the trophic signals to the epithelium, remains unresolved. Later work (2018–2026) has causally validated the phenotype at the whole-community level and produced correlative human biomarkers, but no study has rederived the phenotype from defined taxa or purified mediators, and reviews continue to identify this mechanistic decomposition as an open gap.

Background

Preterm infants are born with an immature intestine: the epithelial lining is underdeveloped, the barrier is 'leaky', and the crypt-villus architecture with its specialized cell types is not yet mature. This immaturity is the proximate basis of necrotizing enterocolitis (NEC), a devastating inflammatory bowel disease of preterm infants, and of postnatal growth faltering. In healthy term infants the gut is colonized in an orderly sequence, beginning with facultative anaerobes that consume oxygen and are later replaced by strict anaerobes such as Bifidobacterium; the earliest colonizers are often called 'pioneer settlers' because they shape the community that follows. In preterm infants this succession is disrupted by antibiotics, delayed feeding and hospitalization, so different infants acquire functionally different early communities — but which community features matter for gut development is unknown.

The relevant experimental tool is the gnotobiotic mouse model: mice raised under sterile conditions (germ-free, GF) whose digestive tract is then deliberately colonized with a defined or known microbial input, so that cause and effect between microbes and host tissue can be tested without the rest of the microbiota confounding the result. Transferring whole fecal communities from human donors into GF mice ('humanized' or transfaunation models) tests whether a donor community's function transfers to the host. A key precedent showed that a single commensal bacterium, Bacteroides thetaiotaomicron, can reprogram epithelial gene expression in gnotobiotic mice (Hooper et al., 2001), making single-taxon and minimal-community tests of epithelial maturation conceptually tractable.

Yu, Lu, Sun, Petrof and Claud (2016) applied this approach to preterm infants. They transfaunated GF mice with fecal microbiota from two individual preterm infants: one with normal weight gain (community M_PI-H) and one with poor weight gain (M_PI-L). M_PI-H, but not M_PI-L, induced in the ileum (the lower small intestine) increased villus height and crypt depth, increased crypt-cell proliferation (Ki-67 staining), higher expression of the intestinal stem-cell marker Lgr5 and of Paneth-cell markers (Lyz1, Cryptdin5) in laser-capture-microdissected crypts, more goblet cells, higher expression of the mature enterocyte/goblet marker Muc3, and continuous apical staining of the tight-junction proteins occludin and ZO-1 (tight junctions are the seals between adjacent epithelial cells that gate intestinal permeability). M_PI-L mice remained morphologically comparable to GF mice. Paneth cells (antimicrobial-peptide-secreting cells at the crypt base, reduced in preterm infants and in NEC) thus served as one readout of induced maturity. The study deliberately used only two individual donor communities, and its discussion states the follow-up agenda: identification of the pioneer settlers that are necessary to induce maturation and of their metabolites — short-chain fatty acids (SCFAs, bacterial fermentation products such as butyrate), folate, bile acids, or vitamins — which may have trophic effects on gut development, supported by tandem microbial transcriptomic/proteomic/metabolomic profiling.

Problem Statement

Identify the specific bacterial taxa or combinations of taxa — the 'pioneer settlers' — within early preterm-infant fecal microbiota that are necessary to induce the ileal epithelial maturation phenotype observed by Yu et al. (2016) in gnotobiotic mice (increased villus height and crypt depth, crypt-cell proliferation with elevated Lgr5 expression, goblet- and Paneth-cell differentiation with induction of Lyz1/Cryptdin5/Muc3, and continuous tight-junction assembly of occludin and ZO-1). Second, identify the microbial-derived molecular mediators — short-chain fatty acids such as butyrate, folate, bile acids, vitamins, or other metabolites — that exert these trophic effects on the epithelial lineages and tight junctions. The overarching objective is a causal decomposition of how the earliest preterm microbial community drives intestinal epithelial maturation.

Throughout this task, 'pioneer settlers' denotes the taxa whose presence is functionally required to drive this coordinated maturation program, not merely the earliest colonizers of the ecological succession described in the Background; in preterm infants the two sets need not coincide. The scientific target is a causal decomposition, proposed as a testable hypothesis: the minimal set of bacterial taxa, or the minimal defined consortium, whose presence is required for the full coordinated program — flagging any member that governs only part of the readout list — together with the microbial-derived mediator(s) responsible for each trophic effect.

References

  1. Yu Y, Lu L, Sun J, Petrof EO, Claud EC (2016). Preterm infant gut microbiota affects intestinal epithelial development in a humanized microbiome gnotobiotic mouse model. American Journal of Physiology-Gastrointestinal and Liver Physiology 311(3):G521-G532. DOI: 10.1152/ajpgi.00022.2016. URL: https://doi.org/10.1152/ajpgi.00022.2016
  2. Lu L, Yu Y, Guo Y, Wang Y, Chang EB, Claud EC (2015). Transcriptional Modulation of Intestinal Innate Defense/Inflammation Genes by Preterm Infant Microbiota in a Humanized Gnotobiotic Mouse Model. PLOS ONE. DOI: 10.1371/journal.pone.0124504. URL: https://doi.org/10.1371/journal.pone.0124504
  3. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI (2001). Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine. Science 291(5505):881-884. DOI: 10.1126/science.291.5505.881. URL: https://doi.org/10.1126/science.291.5505.881
  4. Ma B, McComb E, Gajer P, Yang H, Humphrys M, Okogbule-Wonodi A, Fasano A, Ravel J, Viscardi RM (2018). Microbial Biomarkers of Intestinal Barrier Maturation in Preterm Infants. Frontiers in Microbiology 9:2755. DOI: 10.3389/fmicb.2018.02755. URL: https://doi.org/10.3389/fmicb.2018.02755
  5. Younge NE, Newgard CB, Cotten CM, Goldberg RN, Muehlbauer MJ, Bain JR, Stevens RD, O'Connell TM, Rawls JF, Seed PC, Ashley PL (2019). Disrupted Maturation of the Microbiota and Metabolome among Extremely Preterm Infants with Postnatal Growth Failure. Scientific Reports 9:8167. DOI: 10.1038/s41598-019-44547-y. URL: https://doi.org/10.1038/s41598-019-44547-y
  6. Hiltunen H, Hanani H, Luoto R, Turjeman S, Ziv O, Isolauri E, Salminen S, Koren O, Rautava S (2021). Preterm infant meconium microbiota transplant induces growth failure, inflammatory activation, and metabolic disturbances in germ-free mice. Cell Reports Medicine 2(11):100447. DOI: 10.1016/j.xcrm.2021.100447. URL: https://doi.org/10.1016/j.xcrm.2021.100447
  7. Healy DB, Ryan CA, Ross RP, Stanton C, Dempsey EM (2022). Clinical implications of preterm infant gut microbiome development. Nature Microbiology 7(1):22-33. DOI: 10.1038/s41564-021-01025-4. URL: https://doi.org/10.1038/s41564-021-01025-4
  8. Tsang DKL, Wang RJ, De Sa O, Ayyaz A, Foerster EG, Bayer G, Goyal S, Trcka D, Ghoshal B, Wrana JL, Girardin SE, Philpott DJ (2022). A single cell survey of the microbial impacts on the mouse small intestinal epithelium. Gut Microbes 14(1):2108281. DOI: 10.1080/19490976.2022.2108281. URL: https://doi.org/10.1080/19490976.2022.2108281
  9. Frazer LC, Good M (2022). Intestinal epithelium in early life. Mucosal Immunology 15(6):1181-1187. DOI: 10.1038/s41385-022-00579-8. URL: https://doi.org/10.1038/s41385-022-00579-8
  10. Lu J, Drobyshevsky A, Lu L, Yu Y, Caplan MS, Claud EC (2023). Microbiota from Preterm Infants Who Develop Necrotizing Enterocolitis Drives the Neurodevelopment Impairment in a Humanized Mouse Model. Microorganisms 11(5):1131. DOI: 10.3390/microorganisms11051131. URL: https://doi.org/10.3390/microorganisms11051131
  11. Robertson KM, Cermack K, Woodruff T, Carter SR, Jala VR, Buonpane C (2025). Review: microbial metabolites - a key to address gut inflammation and barrier dysfunction in the premature infant. Gut Microbes. DOI: 10.1080/19490976.2025.2551117. URL: https://doi.org/10.1080/19490976.2025.2551117
  12. Chan Poon KT, Han SH, Ilkayeva O, Muehlbauer MJ, Newgard CB, Cotten CM, Ashley PL, Seed PC, Rawls JF, Younge NE (2026). Microbiotas from extremely preterm infants with growth faltering impair postnatal growth and metabolism in mice. JCI Insight 11(15):e199097. DOI: 10.1172/jci.insight.199097. URL: https://doi.org/10.1172/jci.insight.199097
  13. Li Z, Zhu X, Li J, Hei M (2026). From homeostasis to dysregulation: human milk, microbial metabolites, and the preterm intestinal microenvironment in necrotizing enterocolitis. Translational Pediatrics 15(7):288. DOI: 10.21037/tp-2026-0311. URL: https://doi.org/10.21037/tp-2026-0311